Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTS,S/AS02D infant malaria vaccine EPI co-administration study
2015-001539-19Phase 2
- Sponsor
- GSK
- Start
- May 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of RTS,S in Falciparum malaria (PF) (2 arms), sponsored by GSK. Primary endpoint: Occurrence of serious adverse events.
02
Drugs
RTS,S
03
Conditions
Falciparum malaria (PF)
Beyond the preview
Go deeper on 2015-001539-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001539-19.